EGFR-IN-44 is a potent, orally active inhibitor of EGFRtyrosine kinase (IC50: 4.11 nM). EGFR-IN-44 has an oral bioavailability of 33.57% and induces apoptosis. EGFR-IN-44 can be used to study non-small cell lung cancer.
Molecular Weight:
537.08
Formula:
C27H29ClN6O2S
Target:
Others|||EGFR|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
